Pfizer Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Pfizer Q2 results FY27 announcement is the next scheduled earnings event for Pfizer Ltd., the Indian arm of the global pharmaceutical company, selling prescription medicines and vaccines across pain management, anti-infectives, vitamins and specialty care through a nationwide distribution and prescription network. The stock traded at Rs 4,085.20 on the NSE on 11 September 2026, down 1.00% from the previous close of Rs 4,126.50, about 29.0% below its 52-week high of Rs 5,750.00 and 0.1% above its 52-week low of Rs 4,080.00.

What makes the Pfizer Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 642.00 crore of revenue and a profit of Rs 189.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 653.00 crore and a profit of Rs 204.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Pfizer Q2 Results FY27 Date?

The Pfizer Q2 results date for FY27 is not confirmed. As of 11 September 2026, Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Pfizer Q2 results date becomes public through that filing rather than through any advance announcement.

The Pfizer Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Pfizer.

Pfizer Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Pfizer Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Pfizer. The Pfizer Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is revenue, which was Rs 642 crore in September 2025 against Rs 653 crore in Q1 FY27. Sales have been unusually stable, staying inside a Rs 603 crore to Rs 653 crore band across all five quarters and growing 8% year on year.

The second is the operating margin, which was 36% in September 2025 and 38% in Q1 FY27. Margin has improved from 35% a year ago and is the highest of the window, so the September comparison is a favourable one.

The third is the other income line, which was negative Rs 20 crore in December 2025 against positive Rs 42 crore to Rs 67 crore elsewhere. That swing alone cut December net profit to Rs 142 crore from Rs 189 crore while operating profit was almost unchanged.

Check Pfizer Ltd. Live Fundamentals on the Univest Screener

Pfizer Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Pfizer Ltd. reported revenue of Rs 653.00 crore in Q1 FY27, up 8.29% from Rs 603.00 crore in Q1 FY26, and a profit of Rs 204.00 crore at the net level, up 6.25% from Rs 192.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 3.82% over the March 2026 quarter figure of Rs 629.00 crore, and net profit was up 2.00% from Rs 200.00 crore in Q4 FY26. Operating margin stood at 38% in Q1 FY27 against 36% in the September 2025 quarter, which is the comparison the Pfizer Q2 results print will be read against.

Q2 FY26 Base: The Comparison Pfizer Q2 Results FY27 Must Beat

Pfizer Ltd. reported revenue of Rs 642.00 crore and a profit of Rs 189.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Pfizer Q2 results preview.

Net profit in that base quarter was below the Rs 204.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 642.00 crore sits below the Rs 653.00 crore of the June 2026 quarter, which frames how much sequential movement the Pfizer Q2 results print needs to show growth.

Pfizer Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	642.00	189.00
Q3 FY26 (Dec 2025)	645.00	142.00
Q4 FY26 (Mar 2026)	629.00	200.00
Q1 FY27 (Jun 2026)	653.00	204.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Pfizer Q2 results preview uses.

Revenue across those four quarters ranged from Rs 629.00 crore to Rs 653.00 crore, and net profit from Rs 142.00 crore to Rs 204.00 crore. That spread is the honest context for the Pfizer Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Pfizer Q2 Results FY27

The Pfizer Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Pfizer has already reported.

A Few Brands Carry the Portfolio

A large share of revenue comes from a small set of established prescription brands, so the growth rate depends on prescription volumes and price control decisions on those specific products rather than on a broad pipeline.

Other Income Is a Real Component

Excluding the December swing, other income runs Rs 42 crore to Rs 67 crore a quarter, equal to 18% to 32% of operating profit, and comes from a treasury book funded by Rs 4,157 crore of reserves against only Rs 70 crore of borrowings.

The Share Price Has Fallen Hard

The stock trades at Rs 4,085.20 against a 52-week high of Rs 5,750.00, below both its 50-day average of Rs 4,703.05 and its 200-day average of Rs 4,767.07, with a 14-day RSI of 6.54. The effective tax rate was exactly 26% in all five quarters.

Pfizer Q2 Results FY27: Share Price and Valuation Going Into the Print

Pfizer share price today is Rs 4,085.20 on the NSE, down Rs 41.30 or 1.00% from the previous close of Rs 4,126.50 on 11 September 2026, ahead of the Pfizer Q2 results announcement.

Metric	Value (11 September 2026)
NSE Symbol	PFIZER
Current Market Price	Rs 4,085.20
52-Week High	Rs 5,750.00
52-Week Low	Rs 4,080.00
Market Capitalisation	Rs 18,687 crore
PE Ratio	24.33
PB Ratio	4.45
EPS (TTM)	Rs 167.89
Book Value per Share	Rs 919.00
Debt to Equity	0.02
Return on Equity	18.0%
50-Day Moving Average	Rs 4,703.05
200-Day Moving Average	Rs 4,767.07
RSI (14)	6.54

The stock trades below both its 50-day average of Rs 4,703.05 and its 200-day average of Rs 4,767.07, with a 14-day RSI of 6.54. None of this is a view on where the shares go once the Pfizer Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Pfizer Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Pfizer Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Pfizer Q2 results print in proportion.

1. Revenue against the Rs 642.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 189.00 crore in that same quarter
3. Operating margin against 38% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Pfizer Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Pfizer Q2 Results FY27

The Pfizer Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Pfizer Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Pfizer Q2 results FY27 print faces a base of Rs 642.00 crore in revenue and a profit of Rs 189.00 crore, with the most recent quarter having delivered Rs 653.00 crore and a profit of Rs 204.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Pfizer, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Pfizer Q2 Results FY27

What is the Pfizer Q2 results date for FY27?

Ans. The Pfizer Q2 results date for FY27 is not confirmed. Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE as of 11 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Pfizer Q2 results 2026 cover?

Ans. The Pfizer Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Pfizer Ltd. reports revenue, operating profit and net profit for that period, and the Pfizer Q2 results filing also carries the notes to the accounts.

What were the Pfizer Q1 FY27 results?

Ans. Pfizer Ltd. reported revenue of Rs 653.00 crore in Q1 FY27 and a profit of Rs 204.00 crore at the net level. Revenue was up 8.29% versus Q1 FY26 and net profit was up 6.25% from Rs 192.00 crore in Q1 FY26.

What were Pfizer Q2 FY26 results in the September 2025 quarter?

Ans. Pfizer Ltd. reported revenue of Rs 642.00 crore and a profit of Rs 189.00 crore in Q2 FY26. Operating margin was 36%. Those figures form the base for the Pfizer Q2 results FY27 comparison.

What are the main Pfizer Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Pfizer Q2 results expectations centre on revenue against the Rs 642.00 crore base, net profit against a profit of Rs 189.00 crore, operating margin against 38% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Pfizer share price today ahead of the Q2 earnings?

Ans. Pfizer share price is Rs 4,085.20 on the NSE as of 11 September 2026, down 1.00% from Rs 4,126.50. The stock is about 29.0% below its 52-week high of Rs 5,750.00 and 0.1% above its 52-week low of Rs 4,080.00, at a market capitalisation of Rs 18,687 crore.

Is Pfizer a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Pfizer Ltd. The stock trades at a price-to-book ratio of 4.45 with a return on equity of 18.0%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.